https://neurosciencenews.com/glioma-cancer-pharmacology-23393/
0
0
31 words
0
Comments
A newly developed drug, Vorasidenib, has shown promise in prolonging progression-free survival for patients with a subtype of glioma.
You are the first to view
Create an account or login to join the discussion